Based on bioinformatics analysis of The Cancer Genome Atlas, our study identifies CCL8 as a potential prognostic marker in SKCM and as part of a therapeutic pathway involving M1 macrophages that may be exploited to improve treatment options for patients. This evidence concerns the gene CCL8 and cancer.